The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
NCT01739634
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Diarrhea
Medullary Thyroid Cancer
Interventions
DRUG:
CASAD
Sponsor
Salient Pharmaceuticals Incorporated